According to our new research study on “Medical Perfusion Technology Market Forecast to 2027 – COVID-19 Impact and Analysis – by Technique, Organ Type, and Component,” the market is expected to reach US$ 962.60 million by 2027 from US$ 707.10 million in 2019. The market is estimated to grow at a CAGR of 4.1% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.
Some Leading Companies Analysis as Below- Getinge AB, Medtronic, LivaNova PLC, Terumo Corporation, XVIVO Perfusion, OrganOx Limited, Waters Medical Systems LLC, TransMedics, Organ Recovery Systems, and Xenios AG – a Fresenius Medical Care are among the leading companies operating in the medical perfusion technology market.
Get Sample Copy of this Report at https://www.theinsightpartners.com/sample/TIPRE00019844/
The companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio to meet the rising demands for the medical perfusion technology. For instance, in May 2019, Terumo Cardiovascular Group, a world pioneer in cardiovascular surgery technology, and Talis Clinical, a major supplier of healthcare software solutions, have announced the commercial availability of ACG-Perfusion and ACG-RemoteView Systems in North America.
Organ transplantation is a surgical process carried out when a patient’s organ stops functioning completely. The organ transplant is commonly done for the organs such as heart, liver, and kidney. However, the rising cases of the chronic diseases are leading to the need for transplantation of other organs such as lung, pancreases, cornea, and vascular tissues. Organ transplantation is considered one of the prominent advancements in the modern medical industry.
Check Exclusive Discount on this Report at https://www.theinsightpartners.com/discount/TIPRE00019844/
The increasing number of organ transplantation surgeries worldwide is resulting in the growing demand for organ donation. According to the data published by the United Network for Organ Sharing, a US-based non-profit organization, in 2020, the rate of heart transplantation in the US grew by around 38.0% during the past 5 years. However, this heart transplantation rate is too low as the demand for transplantations in massive. The public-private partnership in assistance with the transplant coordinators has enormously contributed to the improvement of the organ transplantation. The developing and developed countries have witnessed good numbers of the organ transplantation surgeries. For instance, developing countries such as India and Singapore are emerging as medical tourism destinations in the Asia Pacific region. The countries are growing in terms of offering better and advanced medical treatments.
By Software Type
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
By Organ Type
- Perfusion Pumps
- Heart-Lung Machines
- Monitoring Systems
Purchase this Report at https://www.theinsightpartners.com/buy/TIPRE00019844/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi